Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31952975

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2020 Feb
First author
Migden MR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Migden MR
      type
      Author
    2. name
      Khushalani NI
      type
      Author
    3. name
      Chang ALS
      type
      Author
    4. name
      Lewis KD
      type
      Author
    5. name
      Schmults CD
      type
      Author
    6. name
      Hernandez-Aya L
      type
      Author
    7. name
      Meier F
      type
      Author
    8. name
      Schadendorf D
      type
      Author
    9. name
      Guminski A
      type
      Author
    10. name
      Hauschild A
      type
      Author
    11. name
      Wong DJ
      type
      Author
    12. name
      Daniels GA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Migden MR
      type
      Author
    2. name
      Khushalani NI
      type
      Author
    3. name
      Chang ALS
      type
      Author
    4. name
      Lewis KD
      type
      Author
    5. name
      Schmults CD
      type
      Author
    6. name
      Hernandez-Aya L
      type
      Author
    7. name
      Meier F
      type
      Author
    8. name
      Schadendorf D
      type
      Author
    9. name
      Guminski A
      type
      Author
    10. name
      Hauschild A
      type
      Author
    11. name
      Wong DJ
      type
      Author
    12. name
      Daniels GA
      type
      Author
    bibliography ids
    1. nci-bib-f3508be4d688814b956e3369
    book metadata
    content sha256
    e63739760dc296082573ba504eb1ddcdaf10927b872369dce4af12a2a6d661f0
    document type
    citation
    dois
    1. 10.1016/S1470-2045(19)30728-4
    electronic publication date
    display
    2020 Jan 14
    precision
    day
    year
    2020
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:31952975
    immutable id
    pubmed:31952975@e63739760dc296082573ba504eb1ddcdaf10927b872369dce4af12a2a6d661f0
    journal
    abbreviation
    Lancet Oncol
    issn electronic
    1474-5488
    issn print
    1470-2045
    issue
    2
    name
    The Lancet. Oncology
    nlm unique id
    100957246
    pages
    294-305
    volume
    21
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      31952975
      provenance
      batch id
      4c5003fbb78890e89ae1
      provider
      NCBI PubMed ESummary
      record sha256
      6642eeab5961cbbc6189e5ee78d6f64d1defa88217ab2eee22b03755923aef7d
      response sha256
      890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
      retrieved at
      2026-09-09T23:47:48.270700+00:00
      publication date
      display
      2020 Feb
      precision
      month
      year
      2020
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/31952975/
      title
      Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.

      Preserved source evidence · Not medical advice